Alison Weissbrot
Jun 8, 2021

Bayer kicks off $800 million global media review

WPP’s Mediacom held a majority of the account, along with PHD in certain markets.

Getty Images
Getty Images

Pharmaceutical giant Bayer has kicked off a global media review, Campaign US has learned. 

WPP’s MediaCom and Omnicom’s PHD are incumbents on the account, which is estimated to be worth $800 million globally, and are defending the business. A number of other holding companies are expected to participate in the pitch, including Dentsu and IPG.

MediaSense is advising on the review, but did not reply to requests for comment in time for publication.

In 2010, Bayer consolidated its $800 million media business outside of the U.S. with WPP, later handing its estimated $300 million U.S. remit to Mediacom in 2011. In 2014, PHD picked up Bayer’s global media account across five markets from incumbent Initiative, including the pharma giant’s home country, Germany.

In 2019, a Business Insider article wrongly reported that Bayer was putting its global media account into review. Bayer and WPP responded by publicly refuting the story and emphasizing that the pair were maintaining their relationship. 

Bayer has an in-housing component as part of its media buying operations in the U.S. In 2018 the company partnered with S4 Capital’s MightyHive to in-house its programmatic media buying, setting a goal to take most of its digital media buying in the region in-house by 2020. 

In the U.S. that effort was being led by Josh Palau, formerly head of media at Bayer North America. Palau, however, moved over to PHD as head of media activation, signaling a potential shift in strategy for the pharma giant. 

Pharmaceutical and healthcare brands have been a boon for agencies during the pandemic. The Bayer review is another example of a large, global business launching a global review to consolidate business with a single global partner. 

As one of the largest pharmaceutical companies in the world, Bayer operates a consumer health division that makes drugstore staples such as Alka-Seltzer, Claritin and Aleve, as well as a pharmaceutical and crop sciences division. 

PHD and MediaCom declined to comment. Bayer also declined to comment.

Related Articles

Just Published

8 hours ago

WPP's Mark Read sees pay package surge

The holding company's resurgence has resulted in a near-doubling of Read's compensation.

8 hours ago

Mango and other ‘masstige’ brands shutter after ...

Counting their losses in China, affordable fashion and beauty brands are recalibrating their business strategies and turning to the US for expansion.

8 hours ago

The We ❤️ NYC campaign which didn't get much love

Brand creatives and New Yorkers alike wonder who truly owns a mark that’s become emblematic of the city itself.

9 hours ago

Mullen Lintas ropes in Meta's Ram Jayaraman as CCO ...

The creative strategist of Meta takes on the role previously held by Garima Khandelwal, who has moved on from the company.